More importantly, the authors demonstrated that the BLPNs were actually effective for cancer immunotherapy, enhancing antitumor immunogenicity and IDO‐1 inhibition to improve the proliferation of CTLs (Figure 19d). The gene discussed is IDO1; the disease is cancer.